This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Note on Biotech Business Development
Hamermesh, Richard G.; Higgins, Robert F.Case HBS-807032-EEntrepreneurshipTo maximize their effectiveness, color cases should be printed in color. Describes the business development process in biotechnology companies. Topics covered include: participants in the licensing process and their interests, the major steps in the licensing process, the terms that are part of most agreements, and the most contentious issues that arise in the implementation of licensing agreements. Includes color exhibits.Starting at €8.20
-
Cynthia Fisher and the Rearing of ViaCell, Teaching Note
Hamermesh, Richard G.; Higgins, Robert F.; Seefeld, ErinTeaching Note HBS-808115-ETeaching Note for [806002].Starting at €0.00
-
U.S. Food and Drug Administration
Higgins, Robert F.; Hamermesh, Richard G.; Fuller, Virginia A.Case HBS-807050-ELeadership and People ManagementDescribes the U.S. FDA with particular emphasis on its role in the development of new drugs, biologic products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure.Starting at €8.20
-
Computerized Provider Order Entry at Emory Healthcare
Hamermesh, Richard G.; McFarlan, F. Warren; Morgan, Michael; Keil, Mark; Katz, Andrew; LaBorde, DavidCase HBS-311061-EInformation TechnologiesThe Computerized Provider Order Entry at Emory Healthcare case presents one hospital system's efforts to implement computerized provider order entry (CPOE) across all of its hospitals and the challenges they faced in doing so. Issues such as standardizatiStarting at €8.20
-
General Electric, 1984 (Spanish Version)
Aguilar, Francis J.; Hamermesh, Richard G.; Brainard, Caroline E.Case HBS-302S36Knowledge and CommunicationDescribe los primeros cuatro años de permanencia de Jack Welch como CEO de las ofertas de General Electric Co. con las formas Welch ha tratado de actividades de estrategia y planificación del cambio de GE y sus intentos de hacer la empresa más empresarial.Starting at €8.20
-
Northern Drilling Inc.: The Mond Nickel Contract Decision - A Tactical Dilemma in a Growth Strategy
Michael Taylor; Robert BremnerCase IVEY-9B12A038-EMarketing, StrategyNorthern Drilling Inc., an exploration diamond-drilling contractor, has been asked to tender a bid for a lucrative, highly complex contract with Mond Nickel. Northern has no drills or crew currently available to work on the contract, which requires experienced drillers. Compounding the issue is a shortage of skilled labour in the industry. At the same time, Northern's biggest client, Noranda Nickel, is seeing poor geological results on a job in t...Starting at €8.20
-
Northern Drilling Inc.: The Mond Nickel Contract Decision - A Tactical Dilemma in a Growth Strategy (Spanish version)
Michael Taylor; Robert BremnerCase IVEY-9B12AS038Marketing, StrategyNorthern Drilling Inc., an exploration diamond-drilling contractor, has been asked to tender a bid for a lucrative, highly complex contract with Mond Nickel. Northern has no drills or crew currently available to work on the contract, which requires experienced drillers. Compounding the issue is a shortage of skilled labour in the industry. At the same time, Northern's biggest client, Noranda Nickel, is seeing poor geological results on a job in t...Starting at €8.20
-
Bloodbuy
Hamermesh, Richard G.; Norris, MichaelCase HBS-815114-EEntrepreneurshipIn 2015, Chris Godfrey, founder and CEO of Bloodbuy has to consider the best path to growth for his young company that is attempting to disrupt the blood donation industry.Starting at €8.20
-
Amylin Pharmaceuticals B
Hamermesh, Richard G.; Knoop, Carin-IsabelCase HBS-813091-EEntrepreneurshipSupplement for case 809011Starting at €8.20
-
Novasys Medical
Hamermesh, Richard G.; Barley, LaurenCase HBS-810027-EEntrepreneurshipNovasys has developed a new medical device and procedure for the treatment of female stress urinary incontinence that is cheaper and can be performed in doctors' offices. In spite of FDA approval, the American Medical Association has been unwilling to approve the product for reimbursement. The case deals with the company's struggle to obtain a reimbursement code.Starting at €8.20